¿¬±¸µ¿ÇâÁ¤º¸
Á¦¸ñ [NEJM Ãֽź¸°í : COVID-19 ½ÉÇ÷°üÁúȯ ACE, ARBS ¾à¹°Ä¡·á, »ç¸Á·ü ¿äÀÎ]
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

 

 

 

NEJM Ãֽź¸°í : COVID-19 ½ÉÇ÷°üÁúȯ ¾à¹°Ä¡·á-  Angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs)- ÀáÀçÀû À§Çؼº°ú »ç¸Á·ü ¿äÀÎ ¿¬±¸(Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19)




 

º» ¿¬±¸´Â The New England Journal of Medicine 2020³â 5¿ù 1ÀÏÀÚ ¹ßÇ¥µÈ COVID-19 ½ÉÇ÷°üÁúȯÀÇ ¾à¹°Ä¡·á-Angiotensin-converting–enzyme (ACE) inhibitors¿Í Angiotensin-receptor blockers (ARBs) »ç¿ë¿¡ ´ëÇÑ ÀáÀçÀû À§Çؼº Æò°¡¿Í »ç¸Á·ü °ü·Ã¿äÀÎ ¿¬±¸ÀÌ´Ù.

 

Coronavirus disease 2019 (Covid-19)´Â ½ÉÇ÷°üȯÀ» °¡Áö°í Àִ ȯÀڵ鿡°Ô ´õ¿í ½É°¢ÇÑ À§±â¸¦ ÃÊ·¡ÇÑ´Ù.  ¿¬±¸±â°£Àº 2019³â 12¿ù20ÀϺÎÅÍ 2020³â 3¿ù15ÀϱîÁö Covid-19 ·Î ÀÔ¿øÇÑ 8,910¸í ȯÀÚÀÇ Ä¡·á ¹× »ç¸ÁÀ§Çè ¿äÀÎÀ» ºÐ¼®ÇÏ¿´´Ù. ¿¬±¸´ë»óÀÚ´Â ¾Æ½Ã¾Æ, À¯·´ ¹× ºÏ¹Ì 169°³ º´¿ø ÀÔ¿ø±â·Ï µ¥ÀÌÅͺ£À̽º(observational database)¸¦ ºÐ¼®ÇÏ¿© ½ÉÇ÷°üÁúȯ¿¡ ´ëÇÑ ¾à¹°Ä¡·á ACE inhibitors ¹× ARBsÀÇ À§Çؼº Æò°¡ ¹× »ç¸ÁÀ§ÇèÀ» Áõ°¡½ÃÅ°´Â °ü·Ã¿äÀο¡ ´ëÇÑ Æò°¡¿¬±¸ÀÌ´Ù.



 



 

ºÐ¼®°á°ú´Â ºÐ¼® ´ç½Ã Åð¿øÀÌ °¡´ÉÇß´ø Covid-19·Î ÀÔ¿øÇß´ø ȯÀÚ 8,910 ¸í Áß¿¡¼­, ÃÑ 515¸í(5.8%)ÀÌ º´¿ø¿¡¼­ »ç¸ÁÇßÀ¸¸ç, 8,395¸íÀº(94.2%) Åð¿ø ÈÄ¿¡µµ »ýÁ¸Çß´Ù. 

 

º´¿ø ³» »ç¸ÁÀ² Áõ°¡¿Í °ü·ÃÀÖ´Â µ¶¸³¿äÀεéÀº ¾Æ·¡¿Í °°´Ù.

 

1. 65¼¼ ÀÌ»ó ¿¬·É( (mortality of 10.0%, vs. 4.9% among those ≤65 years of age; odds ratio, 1.93; 95% confidence interval [CI], 1.60 to 2.41) (65 ¼¼ ¹Ì¸¸ÀÇ »ç¸Á·üÀº 10.0 %, »ç¸Á·üÀº 4.9 %)

2. °ü»óµ¿¸Æ Áúȯ(10.2%, vs. 5.2% among those without disease; OR, 2.70; 95% CI, 2.08 to 3.51)

3. ½ÉºÎÀü(15.3%, vs. 5.6% among those without heart failure; OR 2.48; 95% CI, 1.62 to 3.79) 

4. ½ÉÀå ºÎÁ¤¸Æ(11.5%, vs. 5.6% among those without arrhythmia; OR, 1.95; 95% CI, 1.33 to 2.86)

5. ¸¸¼º Æó¼â¼º ÆóÁúȯ(14.2%, vs. 5.6% among those without disease; OR, 2.96; 95% CI, 2.00 to 4.40) 

6. ÇöÀç Èí¿¬(9.4%, vs. 5.6% among former smokers or nonsmokers; OR, 1.79; 95% CI, 1.29 to 2.47)

 

 

¾à¹°Ä¡·á¿Í »ç¸Á·ü°úÀÇ °ü·ÃÀ» ºÐ¼®ÇÑ °á°ú, ACE inhibitors (2.1% vs. 6.1%; OR, 0.33; 95% CI, 0.20 to 0.54) »ç¿ëÀ̳ª, ARB(6.8% vs. 5.7%; OR, 1.23; 95% CI, 0.87 to 1.74) ¾à¹°Ä¡·á´Â º´¿ø³»¿¡¼­ »ç¸ÁÀ§ÇèÀ» Áõ°¡½ÃÅ°´Â °Í°ú °ü·ÃÀÌ ¾ø´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù. [¿ø¹®º¸±â]

 

 

 


2020-05-04 ¿ÀÈÄ 5:19:05, Á¶È¸¼ö : 2380